Navigation Links
Delmarva Foundation Implements Medication Therapy Management Program in Maryland and DC
Date:9/26/2007

Local Quality Improvement Organization is part of national effort to

improve health of Medicare beneficiaries

HANOVER, Md., Sept. 26 /PRNewswire-USNewswire/ -- Quality Improvement Organizations (QIOs) across the country are working in partnership with Medicare Part D prescription drug plans (PDPs) and Medicare Advantage plans (MA-PDs) to improve the quality of prescription drug therapy for Medicare beneficiaries. Delmarva Foundation, Medicare's QIO for Maryland and the District of Columbia, implemented a program aimed at helping Medicare beneficiaries use prescription drugs more appropriately and effectively at their local pharmacies.

Through collaboration among Medi-CareFirst BlueCross BlueShield, University of Maryland School of Pharmacy, Howard University School of Pharmacy, and Delmarva Foundation, this program seeks to improve the safety and quality of prescription drug therapy via use of medication therapy management services (MTMS) in community-based pharmacies. MTMS focuses on improving patients' understanding of the medications they are taking and assessing patients' medications for appropriateness, as well as any potential side effects of their prescriptions.

Delmarva's collaboration was unique across the nation in that it involved local schools of pharmacy and targeted actions of community-based pharmacists.

"This initiative is win-win for providers, Medi-CareFirst, pharmacists and especially patients. Medicare beneficiaries have been able to take advantage of the knowledge and expertise of community pharmacists to help them understand their medications and to take more control of managing their own health," said Carmen Tyler Winston, Vice President, Delmarva Foundation. "In addition to providing increased access to prescription drug coverage, this program helps create a higher quality of care for Medicare beneficiaries in Maryland and the District of Columbia who are taking prescription medications."

State by state details of how other QIOs are working in partnership with Medicare Part D prescription drug plans (PDPs) and Medicare Advantage plans (MA-PDs) to improve the quality of prescription drug therapy for Medicare beneficiaries are reported in a Supplement to the July/August Journal of Managed Care Pharmacy. http://amcp.org/data/jmcp/July%20B%20Supplement.pdf

Delmarva Foundation is a national, not-for-profit organization dedicated to improving healthcare quality in over 30 states. Since 1973, Delmarva has assisted in enhancing care in hospitals, nursing homes, home health agencies, medical practices and health plans. Delmarva conducts work that includes quality improvement, quality assurance, utilization review and external quality review. The company's corporate headquarters are located in Easton, Maryland with other offices in Baltimore, Maryland; Washington, DC; Columbia, South Carolina; and Tampa and Tallahassee, Florida. For more information, please visit Delmarva Foundation on the web at http://www.delmarvafoundation.org.

8SOW-MD/DC-HOSP-091307-0043

This material was prepared by Delmarva Foundation, the Medicare Quality Improvement Organization for Maryland and the District of Columbia, under contract with the Centers for Medicare & Medicaid Services, an agency of the U.S. Department of Health and Human Services.


'/>"/>
SOURCE Delmarva Foundation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Woodruff Foundation Grant To Support Doctorate Of Nursing Practice Program
2. Kalam To Lay Foundation Of Vellore Research Center
3. Nippon Foundation To Help Leprosy Patients
4. Parents Launch SV40 Cancer Foundation In Memory of Son
5. Cancer Aid And Research Foundation: Offering Endless Hope To Cancer Patients
6. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
7. PM Launches Healthcare Foundation For India
8. Prime Minister Manmohan Singh, Flags Off Public Health Foundation of India
9. Gates Foundation to donate USD 104 million to TB Alliance
10. MoU for HIV/AIDS Signed by Nigeria and Clinton Foundation
11. Gates Foundation Adopts Fight against Encephalitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... January 20, 2017 , ... Source Vitál Apothecary, a skin and body ... oils, announced the company had a successful visit to the 2017 ECRM Diet, Vitamin ... companies that work in the nutritional, sports and health industries a chance to meet ...
(Date:1/20/2017)... ... January 20, 2017 , ... International Protein, a company based out of Australia ... attended the January ECRM trade show in Hilton Head, SC. , International Protein ... to create a line of products that would elevate her fitness regime. At this ...
(Date:1/20/2017)... ... ... “The Angel”: a heartwarming and earnest tale of faith and believing ... “The Angel” is the creation of published author, Marjorie Lund-Fontaine, a former professional violinist, ... , When asked of her new book, Marjorie says, “‘The Angel’ was written as ...
(Date:1/20/2017)... ... ... “Journey to Christmas:” a beautiful and enchanting tale that teaches children the true meaning of ... three in Oklahoma City, and a devoted woman of faith. , “Becoming a parent ... the back of my mind for years, but actually doing it might have been a ...
(Date:1/19/2017)... , ... January 19, 2017 ... ... the Aerolib Learning Management System: an On-demand E-learning system for Clinical and ... Hospital Administration that is based on Aerolib`s successful education methodology of Disease ...
Breaking Medicine News(10 mins):
(Date:1/20/2017)... , Jan. 20, 2017 Wells Specialty Pharmacy announces ... Howell Branch Rd in Winter Park, Florida ... Park . Operations have been consolidated into the 3796 ... also pleased to announce that Chad Tomlinson , former ... the Company effective immediately. Mr. Tomlinson is a Graduate of ...
(Date:1/20/2017)... 20, 2017 Avillion LLP, a co-developer and ... Mark Weinberg , MD MBA as Chief Medical Officer. Dr Weinberg ... USA . ... Dr Weinberg has spent more than 17 years as a pharmaceutical ... to micro-cap biotech. Over the course of his career, he has ...
(Date:1/19/2017)... Jan. 19, 2017 The global immunomodulators ... by 2025, according to a new study by ... to be predominantly driven by high R&D investments ... large-scale production of new and therapeutically advanced drugs. ... drugs at an unprecedented rate into the immunomodulators ...
Breaking Medicine Technology: